These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 8769189

  • 1. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
    Pescovitz MD, Henson S, Bodziak K, Book BK, Gonin J, Jindal RM, Leapman SB, Milgrom ML, Filo RS.
    Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189
    [No Abstract] [Full Text] [Related]

  • 2. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
    Schiavelli R, Sgrosso JL, Sabbatiello R, Castro C, Ahualli L, Pattin M, Vazquez MC.
    Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
    [No Abstract] [Full Text] [Related]

  • 3. Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients.
    Hoyer PF, Boekenkamp A, Vester U, Offner G, Brodehl J.
    Transplant Proc; 1996 Aug; 28(4):2259-61. PubMed ID: 8769218
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral.
    Serafinowicz A, Gaciong Z, Baçzkowska T, Rell K, Lao M, Wałaszewski J.
    Transplant Proc; 1996 Dec; 28(6):3138-9. PubMed ID: 8962216
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of Neoral in pediatric renal transplantation.
    Ettenger RE, Smith HT, Kaiser B, Cooney GF, Summerauer J, Alexander S, Moulton LT, Choc MG, Wong RL.
    Transplant Proc; 1996 Aug; 28(4):2257-8. PubMed ID: 8769217
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.
    Tsang WK, Ho YW, Tong KL, Chan WH, Chan A.
    Transplant Proc; 1996 Jun; 28(3):1330-2. PubMed ID: 8658681
    [No Abstract] [Full Text] [Related]

  • 12. Oral cyclosporine pharmacokinetics in pediatric renal and liver transplant recipients.
    Cooney GF, Dunn SP, Kaiser B, Kulinsky AV, Mochon M, Heifets M.
    Transplant Proc; 1994 Oct; 26(5):2779-80. PubMed ID: 7940876
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
    First MR, Weiskittel P, Shah M, Peddi VR, Canafax D, Schroeder TJ.
    Transplant Proc; 1998 Dec; 30(8):3955-7. PubMed ID: 9865260
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of conversion from Sandimmune to Neoral on glomerular filtration rate in stable renal transplant recipients.
    Steinmuller D, Dougherty J, Coutee J, Surek D, Swies G, Lewis R.
    Transplant Proc; 1997 Dec; 29(1-2):298-9. PubMed ID: 9123005
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.